Shares of Zydus Lifesciences Ltd ended at ₹889.00, down by ₹10.90, or 1.21%, on the BSE.
Zydus Lifesciences’ venture arm invests in Illexcor Therapeutics for sickle cell disease therapies
Share it
Open an Account in less than 1 Min.
Need help? Call us
+91 976 976 8500
Services
Company
Get in touch
- +91 976 976 8500
- info@markettrade.live
- Pjazza Mifsud Bonnici, Marsascala, Malta
- 333, Pali Pathar, Khar West, Mumbai, Maharashtra 400052
Copyright © 2025 Market Trade